Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Technical Report
  • Published:

Differentiation of human and murine induced pluripotent stem cells to microglia-like cells


Microglia are resident inflammatory cells of the CNS and have important roles in development, homeostasis and a variety of neurologic and psychiatric diseases. Difficulties in procuring human microglia have limited their study and hampered the clinical translation of microglia-based treatments shown to be effective in animal disease models. Here we report the differentiation of human induced pluripotent stem cells (iPSC) into microglia-like cells by exposure to defined factors and co-culture with astrocytes. These iPSC-derived microglia have the phenotype, gene expression profile and functional properties of brain-isolated microglia. Murine iPSC-derived microglia generated using a similar protocol have equivalent efficacy to primary brain-isolated microglia in treatment of murine syngeneic intracranial malignant gliomas. The ability to generate human microglia facilitates the further study of this important CNS cell type and raises the possibility of their use in personalized medicine applications.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Human iPSCs are differentiated into microglia-like cells.
Figure 2: Phenotypic and genotypic analysis indicate human microglia-like cells.
Figure 3: Human iPS-MG demonstrate functional abilities consistent with human microglia.
Figure 4: Mouse iPSCs are differentiated into microglia using a two-stage process.
Figure 5: Mouse iPS-MG display phenotypic markers and gene expression consistent with primary neonatal microglia.
Figure 6: Mouse iPS-MG demonstrate functional abilities of neonatal microglia.
Figure 7: Murine nMG and iPS-MG prolong the survival of tumor-bearing animals.

Similar content being viewed by others


  1. Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314–1318 (2005).

    Article  CAS  Google Scholar 

  2. Davalos, D. et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752–758 (2005).

    Article  CAS  Google Scholar 

  3. Cardona, A.E. et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917–924 (2006).

    Article  CAS  Google Scholar 

  4. Aguzzi, A., Barres, B.A. & Bennett, M.L. Microglia: scapegoat, saboteur, or something else? Science 339, 156–161 (2013).

    Article  CAS  Google Scholar 

  5. Nayak, D., Roth, T.L. & McGavern, D.B. Microglia development and function. Annu. Rev. Immunol. 32, 367–402 (2014).

    Article  CAS  Google Scholar 

  6. Hwang, S.Y. et al. Induction of glioma apoptosis by microglia-secreted molecules: the role of nitric oxide and cathepsin B. Biochim. Biophys. Acta 1793, 1656–1668 (2009).

    Article  CAS  Google Scholar 

  7. Mora, R. et al. TNF-alpha- and TRAIL-resistant glioma cells undergo autophagy-dependent cell death induced by activated microglia. Glia 57, 561–581 (2009).

    Article  Google Scholar 

  8. Brantley, E.C. et al. Nitric oxide-mediated tumoricidal activity of murine microglial cells. Transl. Oncol. 3, 380–388 (2010).

    Article  Google Scholar 

  9. Chicoine, M.R. et al. The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4. Neurosurgery 60, 372–380, discussion 381 (2007).

    Article  Google Scholar 

  10. Sarkar, S. et al. Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells. Nat. Neurosci. 17, 46–55 (2014).

    Article  CAS  Google Scholar 

  11. Saijo, K. & Glass, C.K. Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol. 11, 775–787 (2011).

    Article  CAS  Google Scholar 

  12. Gandy, S. & Heppner, F.L. Microglia as dynamic and essential components of the amyloid hypothesis. Neuron 78, 575–577 (2013).

    Article  CAS  Google Scholar 

  13. Prinz, M., Priller, J., Sisodia, S.S. & Ransohoff, R.M. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 14, 1227–1235 (2011).

    Article  CAS  Google Scholar 

  14. Capotondo, A. et al. Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation. Proc. Natl. Acad. Sci. USA 109, 15018–15023 (2012).

    Article  CAS  Google Scholar 

  15. Chen, S.K. et al. Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 141, 775–785 (2010).

    Article  CAS  Google Scholar 

  16. Biju, K. et al. Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease. Mol. Ther. 18, 1536–1544 (2010).

    Article  CAS  Google Scholar 

  17. Biju, K.C. et al. Bone marrow-derived microglia-based neurturin delivery protects against dopaminergic neurodegeneration in a mouse model of Parkinson's disease. Neurosci. Lett. 535, 24–29 (2013).

    Article  CAS  Google Scholar 

  18. Butovsky, O. et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Invest. 122, 3063–3087 (2012).

    Article  CAS  Google Scholar 

  19. Sedgwick, J.D., Ford, A.L., Foulcher, E. & Airriess, R. Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts. J. Immunol. 160, 5320–5330 (1998).

    CAS  PubMed  Google Scholar 

  20. Vodyanik, M.A., Thomson, J.A. & Slukvin, I.I. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 108, 2095–2105 (2006).

    Article  CAS  Google Scholar 

  21. Butovsky, O. et al. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131–143 (2014).

    Article  CAS  Google Scholar 

  22. Jung, S. et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20, 4106–4114 (2000).

    Article  CAS  Google Scholar 

  23. Napoli, I., Kierdorf, K. & Neumann, H. Microglial precursors derived from mouse embryonic stem cells. Glia 57, 1660–1671 (2009).

    Article  Google Scholar 

  24. Hambardzumyan, D., Gutmann, D.H. & Kettenmann, H. The role of microglia and macrophages in glioma maintenance and progression. Nat. Neurosci. 19, 20–27 (2016).

    Article  CAS  Google Scholar 

  25. Yang, I., Han, S.J., Kaur, G., Crane, C. & Parsa, A.T. The role of microglia in central nervous system immunity and glioma immunology. J. Clin. Neurosci. 17, 6–10 (2010).

    Article  Google Scholar 

  26. Hussain, S.F. et al. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro-oncol. 8, 261–279 (2006).

    Article  CAS  Google Scholar 

  27. Van Gool, S. et al. Dendritic cell therapy of high-grade gliomas. Brain Pathol. 19, 694–712 (2009).

    Article  CAS  Google Scholar 

  28. Beutner, C. et al. Engineered stem cell-derived microglia as therapeutic vehicle for experimental autoimmune encephalomyelitis. Gene Ther. 20, 797–806 (2013).

    Article  CAS  Google Scholar 

  29. Beutner, C., Roy, K., Linnartz, B., Napoli, I. & Neumann, H. Generation of microglial cells from mouse embryonic stem cells. Nat. Protoc. 5, 1481–1494 (2010).

    Article  CAS  Google Scholar 

  30. Tsuchiya, T. et al. Characterization of microglia induced from mouse embryonic stem cells and their migration into the brain parenchyma. J. Neuroimmunol. 160, 210–218 (2005).

    Article  CAS  Google Scholar 

  31. Eglitis, M.A. & Mezey, E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. USA 94, 4080–4085 (1997).

    Article  CAS  Google Scholar 

  32. Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010).

    Article  CAS  Google Scholar 

  33. Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273–280 (2013).

    Article  CAS  Google Scholar 

  34. Muffat, J. et al. Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat. Med. 22, 1358–1367 (2016).

    Article  CAS  Google Scholar 

  35. Bellin, M., Marchetto, M.C., Gage, F.H. & Mummery, C.L. Induced pluripotent stem cells: the new patient? Nat. Rev. Mol. Cell Biol. 13, 713–726 (2012).

    Article  Google Scholar 

  36. Clement, A.M. et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113–117 (2003).

    Article  CAS  Google Scholar 

  37. Merling, R.K. et al. Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells. Blood 121, e98–e107 (2013).

    Article  CAS  Google Scholar 

  38. Pripuzova, N.S. et al. Development of a protein marker panel for characterization of human induced pluripotent stem cells (hiPSCs) using global quantitative proteome analysis. Stem Cell Res 14, 323–338 (2015).

    Article  CAS  Google Scholar 

  39. Chen, G. et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424–429 (2011).

    Article  CAS  Google Scholar 

  40. Senju, S. et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells 27, 1021–1031 (2009).

    Article  CAS  Google Scholar 

Download references


This work was supported by the Intramural Research Programs of the National Institute of Neurological Disorders and Stroke, the National Human Genome Research Institute and the National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Author information

Authors and Affiliations



J.K.P. conceived the project; H.P., M.J.S., D.M.I., Y.C., D.B.M. and J.K.P. designed the experiments; H.P., M.J.S., D.M.I., Y.C., A.B.S., G.K. and M.A.B. performed the experiments; H.P., M.J.S., D.B.M. and J.K.P. analyzed the data; K.R.J. performed microarray data analysis; A.G.E., D.M., C.L.S. and S.G. provided technical support; H.L.M. provided conceptual advice; and H.P., M.J.S., D.B.M. and J.K.P. wrote the manuscript.

Corresponding authors

Correspondence to Dorian B McGavern or John K Park.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 The stage 2 co-culture of human iPS-MG and the astrocyte feeder layers were analyzed by staining with ENTPD1 (CD39).

Co-cultures of human iPS-MG and the astrocyte feeder layers were analyzed by staining with ENTPD1 (CD39), a cell surface protein specific for microglia (right). Isotype antibody (left) was used as a control. Data is representative of two different differentiation experiments.

Supplementary Figure 2 Gene-expression data extracted from the human microarray for the six microglia-specific genes.

Our iMG show high expression of all the six microglia genes whereas the macrophages (Mac) and dendritic cells (DC) exhibit high expression of only selected genes. Data is representative of three different differentiation experiments.

Supplementary Figure 3 The stage 2 co-culture of murine iPS-MG and the astrocyte feeder layers were analyzed by GFP+ cell sorting.

The iPS-MG were differentiated from CX3CR1-GFP+ iPSC cells. The CX3CR1 gene is specifically expressed in microglia, and hence the iPS-MG express GFP and can be conveniently separated from the co-culture through FACs sorting. Data is representative of three different differentiation experiments.

Supplementary Figure 4 miPSC cells generated from Cx3cr1Gfp/+ knock-in mouse embryonic fibroblasts demonstrate properties of identity, authenticity and pluripotency.

Cx3cr1gfp/+ iPSCs stain for alkaline phosphatase (a), express the stem cell markers Oct4 (b) and Sox2 (c), form teratomas (d), can be used to generate chimeric mice (e), and display a normal karyotype (f). Data is representative of three different cell-culture for the alkaline phosphatase and immunocytochemistry experiments and 4 mice for the chimera experiments.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–4 and Supplementary Table 1 (PDF 6827 kb)

Supplementary Methods Checklist (PDF 1093 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pandya, H., Shen, M., Ichikawa, D. et al. Differentiation of human and murine induced pluripotent stem cells to microglia-like cells. Nat Neurosci 20, 753–759 (2017).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing